Reduction of Serum Interleukin-1-Like Activity After Treatment With Dexamethasone
Authors:
- 1 February 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 37 (2) , 193-207
Abstract
The ability of steroids to modulate the appearance of interleukin-1(IL-1) in vivo was evaluated in a model of endotoxin shock. High levels of IL-1 were found in serum from A/J mice which were sensitized with P. acnes and challenged with bacterial lipopolysaccharide (LPS). The factor appeared in the serum 2–4 hours after LPS challenge and was dependent on the period of P. acnes sensitization and the dose of LPS. Treating the mice with dexamethasone prior to LPS challenge resulted in significantly lower thymocyte proliferative activity in the serum. Three experiments demonstrated that this reduced activity reflects a decrease in IL-1. 1) The reduced activity was not due to the presence of proliferation inhibitors since mixing the serum from dexamethasone-treated mice with purified IL-1 or adding the equivalent amount of steroid directly to thymocyte cultures did not reduce the degree of proliferation. 2) When the serum was fractionated by gel filtration, the proliferative activity for both control and steroid treated sera eluted at 10–16 kilodaltons; however, the activity was nearly 50% less in the sample from steroid-treated mice. 3) In addition to thymocyte proliferative activity, IL-1 induces an increase in the serum titer of the acute phase protein known as serum amyloid A. Both serum- and gel- purified samples were able to induce the SAA, but again the samples from steroid-treated mice were much less active. We conclude that the factor produced in vivo has the properties of IL-1 and that the serum titre of the factor is reduced by dexamethasone treatment.Keywords
This publication has 15 references indexed in Scilit:
- Lymphocyte activating factor promotes T-cell growth factor production by cloned marine lymphoma cellsNature, 1980
- Phorbol myristate acetate induces the secretion of an elastase by populations of resident and elicited mouse peritoneal macrophagesBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.The Journal of Immunology, 1980
- Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells.The Journal of Immunology, 1980
- Investigation of the component of Propionibacterium acnes (Corynebacterium parvum) responsible for macrophage activationInfection and Immunity, 1980
- Protection of mice against endotoxin-induced liver damage by anti-inflammatory drugsInflammation Research, 1979
- MECHANISM OF ACTION OF HUMAN B-CELL-ACTIVATING FACTOR .1. COMPARISON OF THE PLAQUE-STIMULATING ACTIVITY WITH THYMOCYTE-STIMULATING ACTIVITY1979
- Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.Journal of Experimental Medicine, 1978
- Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages.Journal of Experimental Medicine, 1978
- HYPERREACTIVITY TO ENDOTOXIN IN MICE INFECTED WITH MYCOBACTERIA - INDUCTION AND ELICITATION OF REACTIONS1961